Facilities

Manufacture of pharmaceutical products

In 2011, the manufacture of pharmaceutical products in volume terms (number of packages) increased by 4.8% (66.6 thousand packages) and amounted to 1,460 million packages. All the production facilities of the company fully comply with Russian national standards, while six production lines at OJSC Pharmstandard-Leksredstva have already received certificates of compliance with the EU GMP standards. All the plants are expected to convert to EU GMP standards by 2014, according to the schedule approved by the company’s management.

OJSC Pharmstandard-Leksredstva

 CEO of OJSC Pharmstandard-Leksredstva: Evgeniy Prohoda

OJSC Pharmstandard-Leksredstva (Kursk) is the biggest manufacturer of finished pharmaceutical products in the Central Black Earth Region and is one of the ten biggest pharmaceutical manufacturers in Russia. Its production capacity is more than 800 million packages per year. Pharmaceutical forms: tablets, aerosols, sprays, capsules, sachets, liquid forms. EU GMP certificates have been issued for six production lines.

In 2011, two new coaters for the manufacture of tablets were brought into operation. The increase in output of pharmaceutical products in 2011 by 18 million packages is attributable to this new development. In 2011, the total capacity of the plant to manufacture tableted products grew by 8% as compared to 2010.Bringing into operation a new sachet packaging machine, OMAG, led to the increase in production of Neosmectin® by 17%.

OJSC Pharmstandard-Tomskhimfarm

CEO of OJSC Pharmstandard-Tomskhimfarm: Andrei Skorokhod 

 OJSC Pharmstandard-Tomskhimfarm (Tomsk) is the biggest manufacturer of finished pharmaceutical products in Western Siberia. The plant produces more than 50 finished pharmaceutical product names; dosage forms - tablets, solutions, aerosols. Production capacity is more than 300 million packages per year.

Following the installation and bringing into operation of a new filling line, SAM, in March 2011, the capacity for the manufacture of coated tablets increased by 25%, production of Formentin® (dosages: 850 ml and 1000 ml) and Pentalgin® (tablets No.4) began. The plant's total capacity to manufacture tablet dosage form products has increased by 5%.

OJSC Pharmstandard-UfaVITA

CEO of OJSC Pharmstandard-UfaVITA: Vladimir Kreyman

OJSC Pharmstandard-UfaVITA (Ufa) is one of the biggest Russian pharmaceutical manufacturers. It holds the leading position in the area of single and multi-vitamin production. Apart from vitamins, the plant manufactures a broad range of pharmaceutical products, including bio-engineered products: insulin (Biosulin®), growth hormone (Rastan®) and filmgrastim (Neipomax®). At present, the range of products includes 80 names. Production capacity is more than 200 million packages per year.

Following the installation and bringing into operation of a new filling line, SAM, in October 2011, the capacity for the manufacture of tablet dosage form products increased by 1,68 million packages a month, which means that the total capacity to manufacture tablet dosage form products has increased by 3%.

Know-how upgrades and technological parameter adjustments resulted in the increase of output capacity for lyophilic products by 15% as compared to a year earlier.

OJSC Pharmstandard-Biolek

CEO of OJSC Pharmstandard-Biolek: Alexander Staschenko

OJSC Pharmstandard-Biolek (Kharkov, Ukraine) is a Top-20 Ukrainian pharmaceutical company and specialises in the production of immunobiological products, vaccines, serums, diagnostic products, nutrient mediums, blood products, hormonal, antiviral, antibacterial and enzymatic drugs.

OJSC Pharmstandard-Biolek's output capacity in 2011 was 10,1 million packages. During 2011, the following facilities were brought into operation: a finished product warehouse, a pharmacy warehouse, a secondary packaging section, a rabies vaccine laboratory and a new water treatment section. Production facilities for homogenisation and filtration sterilisation at the section of liposomal products (using Microfluidics homogeniser) have been constructed and brought into operation. These developments have enabled the plant to increase its production capacity and to launch new types of products.

Production of medical equipment and tools

CEO of OJSC Tyumen Plant of Medical Equipment and Tools: Alexander Nizovcev

OJSC Tyumen Plant of Medical Equipment and Tools (TZMOI) is a leader in the market of steam sterilisers. This plant is the only one in Russia to manufacture cupboard sterilisers with chamber volumes from 400 to 700 litres. In 2011, industrial manufacturing of the following products began: modified collectors for purified water storage (volumes 25 and 50) with a relatively low production cost; a new product, Medical Waste Steriliser (SMO-10); and new hi-tech cupboard sterilisers (GPD-750).

A universal assembly device for assembling joints on the welding line was purchased and brought into operation at the plant - to ensure the highest quality of assembly and welding of joints without the need to produce new assembly devices for each new steriliser model. The process of transferring the production of parts from the automated line to CNC machine tools has began. This will lead to lower expenses for the running of the automated line and increase the equipment utilisation rate at the machinery section.

On June 5, 2011, OJSC Pharmstandard and a group of companies DGM announced the creation of Pharmstandard-Medtechnika LLC, for the purpose of boosting sales of medical equipment used for disinfection and sterilisation. OJSC Pharmstandard and DGM Trading Limited established Moldido Trading Limited to be the sole owner of Pharmstandard-Medtechnika LLC. The share of Pharmstandard in the project amounts to 75% and the share of DGM group of companies to 25%.

This table shows the utilisation level of production facilities with respect to the manufacture of pharmaceutical products

Production
facility
Total floor space, m² Prodution
form
Number of shifts

Producion facility in 2010,
in thousand packages

% of utilisation, 2010

Producion facility in 2011,
in thousand packages

% of utilisation, 2011

New
facilities launched in 2011

% of the incre-
ase in output
capac-
ity

Pharm-
standard-Leksredstva

14'900

Syrops &
liquid
forms

3

71 112

69%

75 929

62%

 


 



 


Tablets

3

602 059

53%

649 352

43%

May 2011

8%

 


 


Sprays

3

14 964

95%

14 964

91%

 


 


 


 


Powders

3

8 966

30%

10 403

17%

July 2011

16%

 


 


Capsules

3

82 877

75%

82 877

47%

 


 


  

Pharm-
standard-UfaVITA

5'850

Ampules

3

18 294

79%

17 079

65%

 


 



 


Frozen-dried preparation

3

4 945

58%

5 703

31%

July2011

15%

 


 


Syrops
& liquid forms

3

8 940

27%

-

0%

 


 


 


 


Tablets

3

149 093

54%

154 133

43%

October 2011

3%

 


 


Vitamin bars (ferrohem- atogen)

3

35 482

69%

36 432

66%

 


 


 


 


Insulin

3

14 400

5%

14 400

7%

 


 


 

Pharm-
standard-Tomsk-himfarm

29'000

Syrops
& liquid forms

3

5 400

6%

5 400

6%

 


 



 


Tablets

3

355 993

35%

372 387

25%

March 2011

5%


 


Sprays

3

9 600

15%

9 600

29%

 


 



 


Ointments

3

2 178

18%

2 178

26%

 


 


 

Pharm-
standard-Biolek

14'900

Syrops
& liquid forms

3

955

51%

970

44%

 


 



 


Ampules

3

8 484

27%

8 623

24%

 


 


 


 


Frozen- dried preparation

3

537

33%

537

34%

 


 


 


 


Powders

3

25

34%

25

44%

 


 


 

 


 


 


 


1 394 304

 


1 460 990

 


 


5%

This table shows the utilisation level of production facilities for the manufacture of medical devices and tools

Name of manufactured product

Unit of measurement

Production facilites as at 31.12.2010

Actual output in 2010

Utilisation level of production facilities in 2010г, %

Production facilities as at 31.12.2011

Actual output in 2011

Utilisation level of production facilities in 2011г, %

Disposable syringes

items

276 000

169 173

61%

276 000

52481

19%

Steam sterilisers (capacity up to 100 l)

items.

9 600

3 133

33%

9 600

2937

31%

Steam sterilisers, 100 l

items

420

109

33%

420

120

29%

Water stills, water collectors

items

7 200

4 867

68%

7 200

4308

60%

Menu
Company profile Mission Strategy Achievments Corporate Governance Shareholder structure Social Policy Products Facilities    Manufacturing Licenses    GMP Standards    Procurement Corporate film Reorganization Company presentations Press releases Financial reports Annual reports Investor tools Investor calendar Analyst Coverage
Corporate film
Markets information WAP version
Delayed according to exchanges regulations. RUSTOCKS.com
Company profile Company presentations Press releases Financial reports Annual reports Investor tools Investor calendar Analyst Coverage
© 2007–2013 All rights reserved.
Terms of use www.pharmstd.com